Results 31 to 40 of about 410,667 (361)
Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review
Background As a modulator of the sphingosine 1-phosphate receptor, siponimod is administered as a therapeutic intervention for multiple sclerosis. A previous phase 3 study first reported siponimod-associated macular edema.
Qingsheng Li+3 more
doaj +1 more source
Retinopathy is one of the most severe diabetes-related complications, and macular edema is the major cause of central vision loss in patients with diabetes mellitus.
Corina-Iuliana Suciu+2 more
semanticscholar +1 more source
Widening use of dexamethasone implant for the treatment of macular edema [PDF]
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.+9 more
core +2 more sources
An image-based deep learning model was developed to detect different morphological patterns of diabetic macular edema based on optical coherence tomography images with high accuracy and transparency.
Qiaowei Wu+16 more
semanticscholar +1 more source
AIM: To compare spectral-domain optical coherence tomography (SD-OCT) with fluorescein angiography (FA) in detecting macular edema in patients with uveitis and analyse discrepancies in the findings obtained by the two methods. METHODS: The study included
Mitkova-Hristova Vesela T.+4 more
doaj +1 more source
Laser treatment in diabetic retinopathy [PDF]
Diabetic retinopathy is a leading cause of visual impairment and blindness in developed countries due to macular edema and proliferative diabetic retinopathy (PDR). For both complications laser treatment may offer proven therapy: the Diabetic Retinopathy
Akduman L+36 more
core +1 more source
Macular edema (ME) is a leading cause of vision loss in both children and adults with uveitis.1–7 Reported rates of uveitic ME (UME) from tertiary referral clinics have ranged from roughly 20% to 3...
Manfred Zierhut, Emmett T. Cunningham
openaire +3 more sources
An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy [PDF]
AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: Thirty-two DME patients were enrolled.
Carnovale, Anna+7 more
core +1 more source
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus worldwide, approximately one third have signs of DR and of these, a further one third of DR is vision-threatening DR ...
Ryan Lee, T. Wong, C. Sabanayagam
semanticscholar +1 more source
Disappearance of diabetic macular hard exudates after hemodialysis introduction. [PDF]
We report herein the disappearance of macular hard exudates after the introduction of hemodialysis in diabetic patients. A 62-year-old woman and a 52-year-old man with diabetes mellitus showed hard exudates in the macula of the left eyes.
Matsuo, Toshihiko
core +1 more source